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Neutral or charge-shifting mutagenesis ofp-actin at positions 3 and 4 strongly influenced the actomyosin interaction under non-rigor conditions. 
The polymerization bchaviour and tropomyosin binding properties on the other hand remained unaffected. 
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I. INTRODUCTION 
The actomyosin interaction generates the force that 
causes contraction in muscle cells and various forms of 
motility in non-muscle cells. The molecular mechanisms 
involved in this chemo-mechanical transduction are 
therefore of great interest. Recent progress in determin- 
ing the 3D-structure of actin and myosin, advances in 
molecular genetics, and development of methods to ma- 
nipulate the components of the actomyosin system at 
the molecular level have brought the analysis of energy 
transduction in the actomyosin system to a new stage 
[l-3]. Some of the results already attained have raised 
serious questions concerning the validity of the classical 
cross-bridge model of muscle contraction [4-g], and the 
possibility of an alternative mechanism bsscd on struc- 
tural transformations in the actin filaments was recently 
suggested [lo]. With the improved techniques to pro- 
duce mutated actin in amounts large enough for bio- 
chemical experiments [I 11, it should be possible to put 
the new model to critical tests. 
The amino terminus of the actin molecule appears to 
be important for the interaction with several actin bind- 
ing proteins including myosin [12-171. In addition, 
myosin has been observed to interact with a carboxy- 
terminal segment of actin located in the proximity of the 
amino terminus in subdomain 1 of the actin:DNase I
structure [12-181. The location of an actomyosin inter- 
face to subdomain 1 in the actin molecule thus appears 
well established and seems to involve four segments of 
the actin sequence formed by residues l-7, 18-28, 95- 
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113, and 361-365 [12,18-271. It is unclear though, which 
role each of these segments plays in the formation and 
functioning of the actomyosin complex. 
In a previous report we showed that a double muta- 
tion at positions 3 and 4 of j%actin replacing the wild 
type aspartic acid residues with lysines (D3K,D4K) 
abolished the interaction of the mutant filaments with 
myosin subfragment 1(Sl), while a double deietion or 
a double replacement with alanines in the same posi- 
tions (D3d,D4d and D3A,D4A respectively) only mar- 
ginally affected the Sl binding [1 11. Here we extend the 
analysis of these fl-actin mutants to include their polym- 
erizing behaviour and myosin interaction as seen by 
viscosity analysis, and by the Sl-ATPase and myosin 
‘motor assays’ respectively. In addition, the interaction 
of &se mutants with skeletal muscle tropomyosin was 
studied. 
2. MATERIALS AND METHODS 
Adenosine triphosphate (ATP), dithiothrcitol (DIT) and bovine 
pancreatic deoxyribonuclease I (DNAse I, EC 3.1.21.1) were from 
Boehringer. Mannheim. Hydroxyapatite (Hypatitc C, lot No. 6654) 
was from Clarkson Chemical Company, Williamsport. PA, USA. and 
CNBr activated Sepharose 4B (Pharmacia-LKB. Sweden) was cou- 
pled with 500 mg DNAse I according to the instructions provided by 
the manufacturer. The volume of the DNase I affinity column WPS 80 
ml. 
Manipulations of DNA followed standard protocols [Zs]. The ex- 
pression and preparation of the wild-type and mutant &actins were 
performed as previously reported [ 11,291. Briefly. an inoculum of S, 
cercvisiar K923 (kiMi& mat::eEUZ+, lmr::TRPi’, ura3, ode& sir3ls. 
MATa at 23°C. MATu at 34°C). transformed with the expression 
plasmid carrying either the wild-type or a mutant j3-actin gene, was 
grown overnight at 34OC in uracil-free medium to select for plasmid 
retention. The culture was then diluted l/l00 into I liter of medium, 
grown for another overnight period at 34°C and then diluted into 10 
liters of yeast rich medium (YEPD) in a fenncntor (Belach AB. Swe- 
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Fig. 1, The homogeneity of the yeast expressed actin after DNase I 
affinity and hydroxyapatite chromatography. Panel (a) shows SDS- 
PAGE and panel (b) isoelectric focusing analysis of the wild-type and 
mutant actins. Wildstypep-actin isdenoted WT while the mutants arc 
la&led as in the text. The IEF gel is oriented with the alkaline side 
facing the top of the figure. 
den). Expression of the heurologous actin was induced by shifting the 
temperature to2?C at the beginning of the log phase. The cells were 
collected by centrifuzation after 18-20 h at the end of the log phase 
and were stored &L -70°C. After suspension i  5 mM Tris+ICI. pH 
7.6,O.l mM CaC&, 0.5 mM ATP, I mM NaNI, containing proteasc 
inhibitors as described earlier I1 I], the cells were disintegrated in a 
bcadmill (Innomed-Konsult, Ttiby, Sweden). After the addition of 
RNAse A and DTT to the final concentrations of 10 ,ug/ml and 0.5 
mM respectively, the resulting lysate was clarified by centrifugation 
and applied to the DNAsc I-Sepharose column which was equili- 
brated with 5 mM Tris-HCI, pH 7,6, 0.1 mM C&12, OS mM ATD, 
0.5 mM DTT, I mM NaN, (G-buffer). After washing. total actin was 
cluted with 40% (v/v) formamide and 10% (v/v) glycerol in Gbuffer. 
concentrated on an Amicon YM-IO membrane and app!ied to a hy- 
droxyapatite column (diameter; 1x23 cm) equilibrated wiih 5 mM 
KPO,, pH 7.6, 0,s mM DTT. The p-actin was separated fram the 
endogenous yeast actin by elution with a linear gradient formed by 60 
ml of 5 mM KPG,. pH 7.6,O.S mM DTT, and 60 ml of 40 mM KPO,. 
pH 7.6, 1.5 mM glycine, 0.5 mM DTT. Each fraction (1.2 ml) was 
collected into tubes containing 60~1 of 10 mM ATP, Fractions con- 
taining p-actin were combined and dialyzed overnight against G- 
buffer. 
Myosin subfragment (SI) was prepared by chymotryptic leavage 
of rabbit skeletal muscle myosin [30] and stored at -20°C in a bulk 
containing 5 mM imidazole, pH 7.0, I5 mM NaCI, 0.1 mM PMSF and 
50% glycerol. Rabbit skeletal muscle tropomyosin was purified ac- 
cording to Smillic 1311 and stored at -20°C. 
Protein concentrations were determined by the method of Bradford 
[32] or spctrophotomctrically at290 nm for actin using an extinction 
coefficient of 0.63, and at 280 nm for St and tropomyosin using 
extinction coefficients of 0.75 and 0.3 respectively. 
Sodium dodecylsulphate polyacrylamidc gel elztrophoresis (SDS- 
PAGE) in the presence of 10% acrylamide was performed according 
to Laemmli [33], or in the case of the tropomyosin assay on 15% 
acry!amidc minige!s as described by Mstsudaira and Burgess [34]. Flat 
bed isoelectric gels with a pH range of 5.0-7.0 were run as previously 
described [I I]. 
The viscosity analysis was performed at 2S°C using Cannon-Man- 
ning viscometers and 0.7 ml samples containing 0.5 mg/ml actin. The 
actin-activated SI ATPase activity was determined at 2X in G- 
buffer containing 2 mM MgC&, 25 p6/ml Sl, and varying concentra- 
tions of filamentous actin in a total volume of 0.5 ml to which I PCi 
of [$‘P]ATP was added. Aliquots of lOO$ were withdrawn at 5 min 
intervals and hydrolyzed phosphate was determined by treating sam- 
ples according to Seals ct al. [35] for scintillation counting. 
For the tropomyosin co-sedimentation assay, samples of tro- 
pomyosin were mixed in G buffer containing 2 mM MgCl, with actin 
in increasing amounts resulting in tropomyositiaain ratios of l:I.B, 
1:7 and 1:28. After incubation for 20 min at room temperature, the 
samples were centrifuged at 30 psi for 20 min in a Beckman airfuge, 
The resulting pellets were washed once in G-buffer containing 2 mM 
MgC&, re-centrifuged and the two supernatants were combined and 
subjected to SDS-PAGE as was the pelleted material. 
The motility assay was performed as described by Kron and Spu- 
dich [36] using rabbit skeletal muscle myosin IOO-300ygIml in 25 mM 
imidatolc, pH 7.0, 25 mM KCI, 5 mM MgCI,, 100 mM DTT (assay- 
buffer) and wild type and mutant actin labeled with tetrameth- 
ylrhjdamine phalloidin (Molecular Probes, Oregon, USA). After ad. 
dition of assay buffer containing 1 mM ATP, filament movement was 
followed using a Zeiss photomicroscope III equipped for cpifluores- 
cence, and with a CCD camera (C2400), an image intensifier and a 
processor (Argus-IO) from Hamamatsu Photonics, and a super-VHS 
video from Panasonic. For velocity determinations of video recorded 
filaments the video signal was time.basecorrected with a 780 Synchro- 
nizer-TBC (BLT). The velocity of an individual filament was dcter- 
mined from the video recordings by 4-5 measurements of the distance 
translocatcd per unit time wheu performing a smooth movement. 
3. RESULTS 
Yeast-expressed p-actin can be isolated by a combi- 
nation of DNase I affinity and hydroxyapatite chrom- 
atography. The SDS-PAGE and IEF analysis of the 
product is seen in Fig. 1. The charge-changing muta- 
tions introduced at the actin amino terminus (D3d,D4d, 
D3K,D4K and D3A,D4A actin) led as expected to 
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Fig. 2. Viscosity analysis of wild-type and mutant pmactins. Polymeri. 
tstion was induwd by addition of either 2 mM ?v?gCIz f:) or O,! M 
KCI @J to 0.5 m&ml of actin in G-buffer at 25°C. The viscosity was 
measured at 2 min intervals. Note that the D3A,D4A mutant actin 
reaches a somewhat lower steady-state viscosity compared to the other 
actins. 
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Fig. 3. The ATPase activity generated by act081 complexes. The 
assay was performed as described in Section 2 incubating 25 @ml Sl 
with either wild-type or mutant actin lilaments at 25°C. Wild-type 
actin is denoted by (G), D3d,D4.4 actin by cn), D3K.D4K actin by (0). 
and DJA,D4A actin by (x). The ATPase activity of SI alone was 0.1 
mol P,/mol SI x s. 
shifts in the position ofp-actin towards the alkaline side 
of the pH gradient when analyzed‘by IEF (Fig. 1 b), and 
the mutations also shifted the elution position from the 
hydroxyapatite column relative to that of endogenous 
yeast actin [l I]. 
The polymerizing behaviour of the three mutants in 
the presence of 2 mM MgCl? or 0.1 M KC1 was indistin- 
guishable from that of the wild-type actin except for the 
D3d,D4d mutant which showed a slightly reduced 
steady-state l vel of relative viscosity, Fig. 2. The criti- 
cal concentration of actin polymerization (A,) for the 
wild type /9-actin under these two salt conditions was 
determined at 0.02 mg/ml in the presence of Mg” ions 
(A,(Mg)) and 0.08 mg/ml in the presence of K* ions 
(A,(K)). The corresponding values for D3~l,D4d actin 
were 0.06 mg/ml and 0.12 mg!ml respectively, while 
those of D3K,D4K actin and D3A,D4A actin did not 
differ significantly from the wild-type values as illus- 
trated by the viscosity curves in Fig. 2. Thus positions 
Table 1 
The average sliding velocity and fraction of motile filaments of the 
different actins as recorded by the myosin ‘motor’ assay 
Actin Sliding Velocity Fraction of motile 
curma) filaments 
Wild type 2.7, s = 0.4 (II = 34) 51% (n = 164) 
D3d,D4d actin I .7, s = 0,4 (n = 13) 17% (n = 393) 
C3K.D4K actin 0 O%(n=316) 
D3A,D4A actin 1.5, s = 0.4 (n = 13) 6% Q = 326) 
The standard deviation and the numbers of lilamcnts traced for each 
actin arc indicated by s and 11, respectively. 
Fig. 4. The actin-tropomysin i teraction sprobed by a co-sediments- 
tion assay and subsequent SDS-PAGE analysis. Tropomyosin and 
each of the actins were mixed al three different ratios and centrifuged. 
The resulting supcmatants and pellets after SDS-PAGE arc shown in 
panels (a) and (b), resptively. Lann with wild-type or mutant actins 
arc lab&d as in Fig. I, and the tropomyositiactia ratio in the incuba- 
tion mixtures analyscd in each lane in the 1riplcLs indicated was from 
left to right: I : I .8, 1:7. 1:28. TMN is a control sample treated as the 
others except that actin was not added. and M shows molecular weight 
markers (from top to bottom 94 kDa, 67 kDa, 43 kDa. 30 kDa, 20.1 
kDa and 14.4 kDa). Note that the amount of tropomyosin decreases 
in the supcrnatants while it increases in the corresponding pellets as 
the amount of added actin is incrcascd. 
3 and 4 appear to be of little importance for the forma- 
tion and stability of actin filaments, though the 
increased A, values obtained with D3d,D4d aain indi- 
cate a slightly reduced polymerizability due to this 
mutation. The reason for an interference with the po- 
lymerization in this case is unclear, especially when con- 
sidering the wild-type behaviour of the other two termi- 
nal mutants. 
Myosin subfragment 1 (Sl) decoration recently 
showed that D3K,D4K actin filaments have almost 
completely lost their ability to bind Sl while the 
D3d,D4d and D3A,D4A mutant actins bound Sl al- 
though with a somewhat distorted arrowhead pattern 
[I 11. However, it became obvious that also these latter 
mutations dramatically influenced the chemo-mechani- 
cal transduction process by reducing the hydrolysis of 
ATP to a similar level as that seen with D3K,D4K actin 
which in turn had an activity close to the ATPase activ- 
ity seen with Sl alone (Fig. 3). These results demon- 
strated a pronounced influence of residues 3 and 4 in 
actin on the actomyosin interaction under non-rigor 
conditions (in the presence of ATP). The ‘motor assay’ 
supported these observations howing that the intro- 
duction of the D3d,D4d and D3A,D4A mutations de- 
creased the average wild-type velocity by 37% and 44%. 
respectively. In addition the number of moving fila- 
ments was reduced (Table I). In the case of the 
D3K,D4K actin filaments, no motility was observed, 
and in one experiment the filaments did not adhere to 
the myosin-coated glass surface. 
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The amino-terminal mutants were also screened for 
their tropomyosin binding properties in a sedimentation 
assay analyzing the supernatants and pellets by SDS= 
PAGE (Fig. 4). In the absence of filamentous actin, 
tropomyosin remained in the supematant but with in- 
creasing concentrations of actin filaments, increasing 
amounts of tropomyosin were observed in the pelleted 
material indicating the formation of actin-tropomyosin 
complexes. All three mutants howed a behaviour indis- 
tinguishable from that of the wild type demonstrating 
that within the limitations of the assay these mutations 
did not influence the tropomyosin binding properties of 
actin. This result agrees with the proposed location of 
the tropomyosin binding site in actin subdomains 3 and 
4 [25]. 
4. DISCUSSION 
Of the regions in the actin molecule that have been 
suggested to interact with myosin, the amino-terminal 
sequences have attracted the largest attention. Despite 
the crosslinking of the myosin heavy chain to residues 
l-12 in actin [12], studies employing antibodies which 
discriminate between the amino- and carboxy-terminal 
parts of the actin sequence l-28 have located the myosin 
association to be close to the carboxy-terminal end of 
this segment [19,20,24]. However, recent studies of the 
acto-$1 interaction, again with antibodies directed 
against residues l-7 in actin, led to the conclusion that 
this part of actin contributes to the formation of the 
actomyosin complex in the presence of ATP [23,27]. 
Hence residues l-28 in actin may form at least two 
different myosin contacts as has also been suggested in 
a more recent crosslinking study 1221. 
As described earlier [1 l] deletion of the aspartic acid 
residues at positions 3 and 4 in the actin amino terminus 
or their replacements with alanines caused recognizable 
changes in the Sl-decoration pattern of these mutated 
actin filaments. Filaments containing the deletion mu- 
tant bound Sl with irregular spacings, and filaments 
with alanine at these positions formed complexes with 
a more blunt angle between the Sl and the filament. 
Here these mutations are shown to strongly impair both 
the acto-Sl ATPase activity and translocational activi- 
ties in the motor assay. This strongly supports the con- 
tention that the amino terminus of actin is an important 
element in the interaction between actin and myosin 
during chamo-mechanical transduction. This view is 
further strengthened by the results obtained with the 
D3K,D4K mutant actin, which clearly demonstrate 
that a complete charge shift in the amino terminus abol- 
ishes the actomyosin interaction. It is noteworthy that 
this mutant acti; polymerizes with the characteristics of
wild-type actin suggesting that this part of the mo!ecule 
is nan-influential in the formation and stability of the 
actin filament. 
Sutoh et al. [37] in a recent study of amino-terminal 
62 
actin mutants expressed in Dictyosteliurn discoidem 
reached similar conclusions with respect o the impor- 
tance of the amino terminus for the actomyosin interac- 
tion as those presented here. In contrast, actin genes 
carrying mutations which partly or fully neutralized the 
negative charge at the amino terminus did not visibly 
alter the phenotype of the yeast S. cerevisiae [38]. These 
findings are difficult to reconcile, but may be related to 
the fact that S. ccrevisiae like other eukaryotes, has at 
least two different myosins at its disposal, myosin I 
(‘minimyosin’) and myosin II (classical musle myosin) 
encoded by the MY02 and M YOZ genes respectively 
[39,40]. The ‘minimyosin’ is essential for yeast viability 
[39] while the myosin II is non-essential although cells 
lacking this protein express an altered budding pattern 
and a distorted cell wall deposition [40,41]. The unal- 
tered phenotype of yeast cells with the mutated en- 
dogenous actin mentioned above therefore seems to 
suggest hat the mutated actin can be utilized by the 
‘minimyosin’ more efficiently than the wild-type actin 
can in the absence of myosin II. .4 more plausible expla- 
nation, perhaps, is that there are other components in 
vivo that allow myosin 11 to function also with the 
actins containing the mutations in the amino terminus. 
Previously we reported on the construction of a yeast 
strain lacking endogenous actin but which was rescued 
by the presence of the plasmid expressing P-actin [42]. 
Preliminary experiments with this strain using plasmid 
shuffling [43] to replace the wild-type B-actin with the 
amino-terminal mutants D3.4,D4d and D3A,D4A actin 
demonstrated that these actins are viable while cells 
expressing only D3K,D4K actin could not be isolated 
suggesting that this mutant action is non-viable (PA and 
RK, to be published elsewhere). This again indicates 
that the D3K,D4K mutation more severely disturbs 
actin function. 
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